Invirase is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Saquinavir Mesylate.
Product ID | 0004-0244_13028dda-e358-48e7-9b56-621a6801223d |
NDC | 0004-0244 |
Product Type | Human Prescription Drug |
Proprietary Name | Invirase |
Generic Name | Saquinavir Mesylate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2004-12-17 |
Marketing Category | NDA / NDA |
Application Number | NDA021785 |
Labeler Name | Genentech, Inc. |
Substance Name | SAQUINAVIR MESYLATE |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2004-12-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021785 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2004-12-17 |
Ingredient | Strength |
---|---|
SAQUINAVIR MESYLATE | 500 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
0004-0244 | Invirase | saquinavir mesylate |
0004-0245 | Invirase | saquinavir mesylate |
53808-0674 | Invirase | saquinavir mesylate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INVIRASE 74479082 1987460 Live/Registered |
HOFFMANN-LA ROCHE INC. 1994-01-14 |